Fabien ZOULIM

Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He is Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 where he is leading the team on ‘Antiviral therapy of viral hepatitis’. Dr Zoulim has served as an Associate Editor for Journal of Hepatology and is currently Associate Editor for Gut. He also served as an expert in the microbiology study section of the INSERM and as coordinator of the clinical viral hepatitis study section at ANRS. He served as a Governing Board member of the European Association for the Study of the Liver (EASL). Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. Furthermore, he has been the scientific coordinator of a European community-funded Network of Excellence on the management of antiviral drug resistance, and is currently head of the ANRS “HBV cure” program in France. He co-founded the International Coalition to Eliminate HBV (ICE-HBV: http//:www.ice-hbv.org). Fabien Zoulim is a recognized expert in the field of viral hepatitis and antiviral therapy, and has published more than 400 articles (H index 72, Web of Science).

Chair(s)

Chair - Meet the Experts: Hepatitis B: Which new drugs are in development and how do they work? 13 April 2019 12:30 - 13:20
Meet the Experts
More ...
Chair - Research Think Tank - Hepatitis B cure 10 April 2019 08:00 - 11:00
Workshop
More ...

Presentations

Discussion: Is HBV cure possible and how is it defined? Where are the obstacles? 10 April 2019 09:00 - 09:30
Discussion: What are the best concepts to cure HBV? What are the technical requirements? How should we do the studies? 10 April 2019 10:30 - 11:00